TNBI — Tanke Biosciences Share Price
Last trade - 00:00- $1.46m
- $5.94m
- $28.56m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.09 | ||
| Price to Tang. Book | 0.1 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 0.06 | ||
| EV to EBITDA | 5.47 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -0.35% | ||
| Return on Equity | -10.22% | ||
| Operating Margin | -0.25% | ||
Financial Summary
| Year End 31st Dec | Unit | 2008 | 2009 | 2010 | 2011 | 2012 | 2013E | 2014E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | n/a | n/a | 20.1 | 23.83 | 28.56 | n/a | n/a | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Tanke Biosciences Corp is a company principally engaged in the provision of animal nutrition and feed additive. The Company operates its businesses through four segments. The Organic Trace Mineral Additives segment mainly engaged in the development and production of chelated organic trace minerals additives. The Functional Regulation Additives segment mainly produces feed acidifiers and flavor enhancers. The Herbal Medicinal Additives segment primarily produce and sell products that are derived from Chinese natural plants, herbs and minerals. The Other Revenues segment is mainly engaged in various businesses including the domestic distribution of raw materials and providing technical support and know-how to customers.
Directors
- Last Annual
- December 31st, 2012
- Last Interim
- September 30th, 2013
- Incorporated
- November 1st, 2007
- Public Since
- February 10th, 2011
- No. of Shareholders
- 58
- No. of Employees
- 130
- Sector
- Food & Tobacco
- Industry
- Consumer Defensives
- Exchange
- Pink Sheets on Nasdaq
- Shares in Issue
- 25,464,279
- Address
- No. 519 Machang Road, GUANGZHOU, 510627
- Web
- Phone
- +86 2038859025
- Auditors
- UHY LLP
Similar to TNBI
Adia Nutrition
Pink Sheets on Nasdaq
African Agriculture Holdings
Pink Sheets on Nasdaq
Agri-Dynamics
Pink Sheets on Nasdaq
Agristar
Pink Sheets on Nasdaq
Aifarm
Pink Sheets on Nasdaq
FAQ
As of Today at 22:34 UTC, shares in Tanke Biosciences are trading at $0.06. This share price information is delayed by 15 minutes.
Shares in Tanke Biosciences last closed at $0.06 and the price had moved by +51.59% over the past 365 days. In terms of relative price strength the Tanke Biosciences share price has outperformed the S&P500 Index by +27.43% over the past year.
There is no consensus recommendation for this security.
Find out moreTanke Biosciences does not currently pay a dividend.
Tanke Biosciences does not currently pay a dividend.
Tanke Biosciences does not currently pay a dividend.
To buy shares in Tanke Biosciences you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $0.06, shares in Tanke Biosciences had a market capitalisation of $1.46m.
Here are the trading details for Tanke Biosciences:
- Country of listing: United States
- Exchange: PNK
- Ticker Symbol: TNBI
Based on an overall assessment of its quality, value and momentum Tanke Biosciences is currently classified as a . The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Tanke Biosciences. Over the past six months, its share price has outperformed the S&P500 Index by +120.5%.
As of the last closing price of $0.06, shares in Tanke Biosciences were trading +74.67% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Tanke Biosciences PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $0.06.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Tanke Biosciences' management team is headed by:
- Guixiong Qiu - CHM
- Xugang Shu - VRD
- Bo Jun - DMK